These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34505199)
1. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. Kumar NAN; Jose A; Usman N; Rajan K; Munisamy M; Shetty PS; Rao M Langenbecks Arch Surg; 2022 Feb; 407(1):87-98. PubMed ID: 34505199 [TBL] [Abstract][Full Text] [Related]
2. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study. Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213 [TBL] [Abstract][Full Text] [Related]
3. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country. Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903 [TBL] [Abstract][Full Text] [Related]
4. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107 [TBL] [Abstract][Full Text] [Related]
5. Signet ring cell carcinoma of the gastrointestinal tract: National trends on treatment effects and prognostic outcomes. Franko J; Le VH; Tee MC; Lin M; Sedinkin J; Raman S; Frankova D Cancer Treat Res Commun; 2021; 29():100475. PubMed ID: 34655861 [TBL] [Abstract][Full Text] [Related]
6. [Advances in the research of gastric signet ring cell carcinoma]. Xu Z; Jin Y; Fang X Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1196-1200. PubMed ID: 30370520 [TBL] [Abstract][Full Text] [Related]
7. The differences in biological behavior and gene expression characteristics between pure and mixed early gastric signet ring cell carcinomas. Wang X; Li X; Yang P; Qin X; Yu J; Cheng Y; Zhang G; Tang L Dig Liver Dis; 2023 Jun; 55(6):815-822. PubMed ID: 36529637 [TBL] [Abstract][Full Text] [Related]
8. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Lu M; Yang Z; Feng Q; Yu M; Zhang Y; Mao C; Shen L; Tang J Medicine (Baltimore); 2016 Jul; 95(27):e4052. PubMed ID: 27399088 [TBL] [Abstract][Full Text] [Related]
9. Difference Between Signet Ring Cell Gastric Cancers and Non-Signet Ring Cell Gastric Cancers: A Systematic Review and Meta-Analysis. Zhang C; Liu R; Zhang WH; Chen XZ; Liu K; Yang K; Chen XL; Zhao LY; Chen ZX; Zhou ZG; Hu JK Front Oncol; 2021; 11():618477. PubMed ID: 34026606 [No Abstract] [Full Text] [Related]
10. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach. Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639 [TBL] [Abstract][Full Text] [Related]
11. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study. Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584 [TBL] [Abstract][Full Text] [Related]
12. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755 [TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets. Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879 [TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model. Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943 [TBL] [Abstract][Full Text] [Related]
15. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy. Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes. Yen HH; Chen PY; Huang RY; Jeng JM; Lai IR J Pathol Clin Res; 2024 Jul; 10(4):e12387. PubMed ID: 38860888 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review. An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases. Terada T Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309 [TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features. Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691 [TBL] [Abstract][Full Text] [Related]
20. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study. Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]